This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

[Tc-99m]-Medronate (2017-09-22)

Starting date:
September 22, 2017
Posting date:
October 6, 2017
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
Hospitals, Healthcare Professionals, General Public
Identification number:
RA-64810

Affected products

[Tc-99m]-Medronate

Reason

The sterility may be out of specification in the affected lots.

Depth of distribution

3 Hospitals located in Hamilton, Ontario, Canada

Affected products

[Tc-99m]-Medronate

DIN, NPN, DIN-HIM
No market authorization
Dosage form

Liquid

Strength

14.30, 3.39, and 4.87 GBq
12.39 and 8.66 GBq

Lot or serial number

M-170830MDP-1, M-170830MDP-2,
M-170830MDP-3
M-170905MDP-1, M-170905MDP-2

Companies
Recalling Firm
Centre for Probe Development and Commercialization (CPDC)
1280 Main St. W. NRB-A316
Hamilton
L8S 4K1
Ontario
CANADA
Marketing Authorization Holder
Not Applicable

Date modified: